Incarnation Children's Center

Last updated

Incarnation Children's Center (ICC) is a nursing facility for children living with HIV in New York City. From 1989 until 2000 the center operated as a foster care boarding home; since then it has concentrated on providing medical care. The ICC is a non-profit corporation affiliated with the Archdiocese of New York and Columbia University. From the late 1980s through 2005, foster children at the center with HIV/AIDS were enrolled on clinical trials of antiretroviral medication, which was successful in reducing the death rate from AIDS. [1] In 2005, the center was the focus of "Guinea Pig Kids", a BBC documentary alleging ethical violations in these clinical trials. [1] The allegations prompted an investigation by the Vera Institute of Justice, which concluded that no children had died as a result of the trials, but that the center had kept poor records and sometimes failed to follow its own enrollment policies. [2] Subsequently, the BBC apologized for "very serious issues" in "Guinea Pig Kids", and conceded that the documentary made misleading allegations and was biased toward the views of AIDS denialists. [3] [4]

40°50′36″N73°56′12″W / 40.84332°N 73.9366°W / 40.84332; -73.9366

Related Research Articles

<span class="mw-page-title-main">Zidovudine</span> Antiretroviral medication

Zidovudine (ZDV), also known as azidothymidine (AZT), was the first antiretroviral medication used to prevent and treat HIV/AIDS. It is generally recommended for use in combination with other antiretrovirals. It may be used to prevent mother-to-child spread during birth or after a needlestick injury or other potential exposure. It is sold both by itself and together as lamivudine/zidovudine and abacavir/lamivudine/zidovudine. It can be used by mouth or by slow injection into a vein.

The management of HIV/AIDS normally includes the use of multiple antiretroviral drugs as a strategy to control HIV infection. There are several classes of antiretroviral agents that act on different stages of the HIV life-cycle. The use of multiple drugs that act on different viral targets is known as highly active antiretroviral therapy (HAART). HAART decreases the patient's total burden of HIV, maintains function of the immune system, and prevents opportunistic infections that often lead to death. HAART also prevents the transmission of HIV between serodiscordant same-sex and opposite-sex partners so long as the HIV-positive partner maintains an undetectable viral load.

<span class="mw-page-title-main">Nevirapine</span> Chemical compound

Nevirapine (NVP), sold under the brand name Viramune among others, is a medication used to treat and prevent HIV/AIDS, specifically HIV-1. It is generally recommended for use with other antiretroviral medications. It may be used to prevent mother to child spread during birth but is not recommended following other exposures. It is taken by mouth.

This is a list of AIDS-related topics, many of which were originally taken from the public domain U.S. Department of Health Glossary of HIV/AIDS-Related Terms, 4th Edition.

This is a timeline of HIV/AIDS, including but not limited to cases before 1980.

<span class="mw-page-title-main">AIDS Clinical Trials Group</span>

The AIDS Clinical Trials Group network (ACTG) is one of the largest HIV clinical trials organizations in the world, playing a major role in setting standards of care for HIV infection and opportunistic diseases related to HIV and AIDS in the United States and the developing world. The ACTG is composed of, and directed by, leading clinical scientists in HIV/AIDS therapeutic research. The ACTG is funded by the Department of Health and Human Services, National Institutes of Health through the National Institute of Allergy and Infectious Diseases.

Armenicum is a drug invented in Armenia in 1998 that its developers claim is an effective treatment for HIV infection and a number of associated diseases. No rigorously monitored clinical trials of Armenicum have been published, and most HIV experts outside of Armenia do not endorse its use.

Jonathan Fishbein is an American physician and former director of the National Institutes of Health (NIH) Office for Policy in Clinical Research Operations. In 2005, Fishbein alleged that an NIH-funded clinical trial of the antiretroviral drug nevirapine, conducted in Africa, was invalid because of poor data collection, faulty record-keeping, and lax quality control. The NIH subsequently attempted to fire Fishbein, and he sought protection as a whistleblower.

The history of HIV/AIDS in Australia is distinctive, as Australian government bodies recognised and responded to the AIDS pandemic relatively swiftly, with the implementation of effective disease prevention and public health programs, such as needle and syringe programs (NSPs). As a result, despite significant numbers of at-risk group members contracting the virus in the early period following its discovery, Australia achieved and has maintained a low rate of HIV infection in comparison to the rest of the world.

With 1.28 percent of the adult population estimated by UNAIDS to be HIV-positive in 2006, Papua New Guinea has one of the most serious HIV/AIDS epidemics in the Asia-Pacific subregion. Although this new prevalence rate is significantly lower than the 2005 UNAIDS estimate of 1.8 percent, it is considered to reflect improvements in surveillance rather than a shrinking epidemic. Papua New Guinea accounts for 70 percent of the subregion's HIV cases and is the fourth country after Thailand, Cambodia, and Burma to be classified as having a generalized HIV epidemic.

Michael S. Saag is a physician and prominent HIV/AIDS researcher at the University of Alabama at Birmingham (UAB). He holds the Jim Straley Chair in AIDS Research, is Director of the Division of Infectious Disease and of the William C. Gorgas Center for Geographic Medicine, and Director of the Center for AIDS Research. He is also the founder of the 1917 Clinic, a comprehensive AIDS treatment and research center at UAB Saag is a frequent lecturer at AIDS conferences around the world and is credited with performing pioneering clinical trials for several antiretroviral drugs now in common use for HIV treatment and for first demonstrating the clinical value of "viral-load testing" in HIV/AIDS treatment. In 2009 Saag was elected chairman of the HIV Medicine Association of the Infectious Diseases Society of America. In 2019 Saag began serving on the Presidential Advisory Council on HIV/AIDS.

Patrick Spencer Cox was an American HIV/AIDS activist. He was involved in ACT UP New York and the Treatment Action Group during the height of the AIDS Crisis in New York. He helped facilitate the production of protease inhibitors, which revolutionized AIDS care in the 1990s.

Deborah Persaud is a Guyanese-born American virologist who primarily works on HIV/AIDS at Johns Hopkins Children's Center.

<span class="mw-page-title-main">Mary Jane Rotheram-Borus</span> American licensed psychologist

Mary Jane Rotheram-Borus is a licensed clinical psychologist and professor with the University of California, Los Angeles, Department of Psychiatry and Biobehavioral Sciences. Rotheram is the professor-in-residence in the Semel Institute for Neuroscience and Human Behavior. She is the Director of the Global Center for Children and Families at UCLA and the former director of the Center for HIV Identification, Prevention, and Treatment Services.

HIV in pregnancy is the presence of an HIV/AIDS infection in a woman while she is pregnant. There is a risk of HIV transmission from mother to child in three primary situations: pregnancy, childbirth, and while breastfeeding. This topic is important because the risk of viral transmission can be significantly reduced with appropriate medical intervention, and without treatment HIV/AIDS can cause significant illness and death in both the mother and child. This is exemplified by data from The Centers for Disease Control (CDC): In the United States and Puerto Rico between the years of 2014–2017, where prenatal care is generally accessible, there were 10,257 infants in the United States and Puerto Rico who were exposed to a maternal HIV infection in utero who did not become infected and 244 exposed infants who did become infected.

HPA-23, sometimes known as antimonium tungstate, is an antiretroviral drug that was used for the treatment of HIV infection. It achieved widespread publicity as an effective treatment for HIV and AIDS beginning in 1984, just one year after HIV was first identified. Later testing failed to demonstrate any efficacy and some patients suffered serious side effects from the drug, including liver failure.

Jeffrey T. Parsons is an American psychologist, researcher, and educator; he was a Distinguished Professor of Psychology at Hunter College and The Graduate Center of the City University of New York (CUNY) and was the Director of Hunter College's Center for HIV/AIDS Educational Studies & Training, which he founded in 1996. Parsons was trained as a developmental psychologist and applied this training to understand health, with a particular emphasis on HIV prevention and treatment. He was known for his research on HIV risk behaviors of gay, bisexual, and other men who have sex with men (GBMSM), HIV-related syndemics, and sexual compulsivity. He resigned his positions at CUNY on July 3, 2019, following a year-long university investigation of misconduct allegations against him. In 2023, the U.S. Attorney's Office announced that he was required to pay a $375,000 settlement for engaging in fraud against the federal government for many years.

Many women have been infected with the HIV/AIDS virus. The majority of HIV/AIDS cases in women are directly influenced by high-risk sexual activities, injectional drug use, the spread of medical misinformation, and the lack of adequate reproductive health resources in the United States. Women of color, LGBT women, homeless women, women in the sex trade, and women intravenous drug users are at a high-risk for contracting the HIV/AIDS virus. In an article published by the Annual Review of Sociology, Celeste Watkins Hayes, an American sociologist, scholar, and professor wrote, "Women are more likely to be forced into survival-focused behaviors such as transactional sex for money, housing, protection, employment, and other basic needs; power-imbalanced relationships with older men; and other partnerings in which they cannot dictate the terms of condom use, monogamy, or HIV." The largest motivator to become part of the sex trade was addiction, the second largest being basic needs, and the third was to support their children/family.

Francine Cournos is Professor of Clinical Psychiatry at the Columbia University Mailman School of Public Health. Cournos is also Principal Investigator of the Northeast Caribbean AIDS Education and Training Center at the HIV Center for Clinical and Behavioral Studies.

James M. Oleske is an American pediatrician and HIV/AIDS researcher who is the emeritus François-Xavier Bagnoud (FXB) Professor of Pediatrics at Rutgers New Jersey Medical School in Newark, New Jersey. He is best known for his pioneering work in identifying HIV/AIDS as a pediatric disease, and treating and researching it beginning in the 1980s. He published one of the first articles identifying HIV/AIDS in children in JAMA in 1983 and was a co-author of one of the articles by Robert Gallo and others identifying the virus in Science in 1984.

References

  1. 1 2 Scott, Janny; Leslie Kaufman (July 17, 2005). "Belated Charge Ignites Furor Over AIDS Drug Trial". The New York Times .
  2. ↑ Foderaro, Lisa (January 27, 2009). "Study Refutes Claims on AIDS Drug Trials". The New York Times .
  3. ↑ Holmwood, Leigh (October 23, 2007). "'Serious concern' at BBC over flawed HIV film". The Guardian .
  4. ↑ "Summaries of upheld complaints" (PDF). BBC Editorial Complaints Unit. Archived from the original on May 10, 2019. Retrieved March 28, 2014.{{cite web}}: CS1 maint: bot: original URL status unknown (link)


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.